9 completed. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
Follow Peritoneal Cancer: new trials by email Literature Review of Peritoneal Cancer trials Research Report on Peritoneal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib Rucaparib - Metastatic Castration-Resistant Prostate Cancer, Ovarian Cancer | Phase 3 | Completed | pharmaand GmbH | 34 | 2021-03-22 | 2024-05-07 |
| A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Mirvetuximab Soravtansine - Epithelial Ovarian Cancer, Peritoneal Cancer | Phase 3 | Completed | ImmunoGen, Inc. | 106 | 2020-07-23 | 2024-08-07 |
| A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRĪ±) Expression Mirvetuximab Soravtansine, Paclitaxel, Topotecan - Epithelial Ovarian Cancer, Peritoneal Cancer | Phase 3 | Completed | AbbVie | 453 | 2019-12-31 | 2025-08-27 |
| Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on an Enhanced Recovery Pathway Local Anesthetic Solution, Bupivacaine HCl, Liposomal Bupivacaine - Peritoneal Cancer | Phase 3 | Completed | M.D. Anderson Cancer Center | 75 | 2017-11-27 | 2022-02-18 |
| ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Chemotherapy, Rucaparib - Ovarian Cancer, Epithelial Ovarian Cancer | Phase 3 | Completed | pharmaand GmbH | 349 | 2017-03-01 | 2023-06-09 |
| Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) Rucaparib, Placebo - Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Completed | pharmaand GmbH | 564 | 2014-04-07 | 2023-06-09 |
| Accelerating Gastrointestinal Recovery Alvimopan, Placebo - Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Completed | Jamie N. Bakkum-Gamez | 146 | 2013-01-01 | 2016-10-24 |
| Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer Early post-operative enteral feeding - Epithelial Ovarian Cancer, Peritoneal Cancer | Phase 3 | Completed | Queensland Centre for Gynaecological Cancer | 109 | 2009-01-01 | 2014-06-12 |
| Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane Tamoxifen, Chemotherapy - Ovarian Cancer, Peritoneal Cancer | Phase 3 | Completed | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 241 | 2002-03-01 | 2016-04-05 |
Fallopian Tube Neoplasms (8) · Ovarian Neoplasms (6) · Carcinoma, Ovarian Epithelial (5) · Genital Neoplasms, Male (1) · Malnutrition (1) · Neoplasms (1) · Prostatic Neoplasms (1) · Recurrence (1)
Adnexal Diseases (8) · Endocrine Gland Neoplasms (8) · Endocrine System Diseases (8) · Fallopian Tube Diseases (8) · Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Genital Diseases (8) · Genital Diseases, Female (8) · Genital Neoplasms, Female (8) · Gonadal Disorders (8) · Neoplasms by Site (8) · Ovarian Diseases (8) · Urogenital Diseases (8) · Urogenital Neoplasms (8) · Neoplasms (7)
Paclitaxel (3) · rucaparib (3) · Drug Therapy (2) · liposomal doxorubicin (2) · mirvetuximab soravtansine (2) · Bupivacaine (1) · CP protocol (1) · Carboplatin (1) · Cisplatin (1) · Gemcitabine (1) · Tamoxifen (1) · Topotecan (1) · alvimopan (1)
pharmaand GmbH (3) · AbbVie (1) · ImmunoGen, Inc. (1) · Jamie N. Bakkum-Gamez (1) · M.D. Anderson Cancer Center (1) · Nordic Society of Gynaecological Oncology - Clinical Trials Unit (1) · Queensland Centre for Gynaecological Cancer (1)
United States (6) · Israel (5) · Italy (5) · Australia (4) · Canada (4) · Poland (4) · Spain (4) · United Kingdom (4) · Belgium (3) · Czechia (3) · Germany (3) · Russia (3) · Bulgaria (2) · France (2) · Ukraine (2)
Andreas Obermair, MD FRANZCOG CGO (1) · Gunnar B Kristensen, Prof (1) · Heidi Giordano (1) · Jamie Bakkum-Gamez, MD (1) · Juan P. Cata, MD (1) · Michael Method, MD, MPH, MBA (1) · Robert Coleman, MD (1) · Ursula Matulonis, MD (1)
PMID 25827292, PMID 28916367, PMID 32359490, PMID 32861537, PMID 35170751, PMID 35298906, PMID 35397664, PMID 36716407, PMID 37212825, PMID 37262961, PMID 38055253, PMID 38858103, PMID 39914419, PMID 40179908
2016 (1), 2019 (1)